0001062993-22-005202.txt : 20220222 0001062993-22-005202.hdr.sgml : 20220222 20220222213429 ACCESSION NUMBER: 0001062993-22-005202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Washer Susan B. CENTRAL INDEX KEY: 0001598540 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 22660457 MAIL ADDRESS: STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP. STREET 2: 11801 RESEARCH DRIVE, SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-02-18 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001598540 Washer Susan B. C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA FL 32615 1 1 0 0 President and CEO Common Stock 2022-02-18 4 M 0 120686 0.35 A 152971 D Common Stock 2022-02-18 4 S 0 9950 2.18 D 143021 D Stock Option (right to buy) 0.35 2022-02-18 4 M 0 120686 0 D 2023-01-06 Common Stock 120686 0 D The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.22, inclusive. Option is fully-vested and was exercisable for shares of common stock at any time until the expiration of the option at the holder's election. The reporting person undertakes to provide to Applied Genetic Technologies Corporation, any security holder of Applied Genetic Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 above. /s/ Stacie Aarestad, Attorney-in-fact 2022-02-22